Prostate cancer decisions — 2024

Your original claim for service connection for prostate cancer has been denied, and the appeal is dismissed as there are no unresolved issues to review.

The Board has granted service connection for hypertension and residuals of prostate cancer based on the presumption of exposure to herbicide agents due to service in or near the Korean DMZ.

The Board has remanded several issues related to the Veteran's claims, including service connection for prostate cancer and various musculoskeletal and psychiatric disabilities. The issues of service connection for left hand carpal tunnel syndrome, bilateral shoulder disability, acquired psychiatric disability (including anxiety and/or PTSD), sleep disability (including apnea), left hip disability, right hip disability, left leg disability, and right leg disability are all remanded due to duty-to-assist errors.

The Veteran's claim for an initial compensable rating for erectile dysfunction was denied. The Board found that the evidence did not show any penile deformity or abnormality, and thus the criteria for a compensable rating were not met.,The claims for earlier effective dates for service connection for erectile dysfunction and SMC based on loss of use of a creative organ were dismissed as there is no remaining case or controversy. The Veteran was already in receipt of these benefits from February 7, 2012.

The Board has remanded the cases for further development due to inadequate compliance with previous remand directives. The Veteran's claims of increased rating for left knee disability, service connection for left hip disability, and service connection for prostate cancer are all being reviewed.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of herbicide exposure during his deployment to Korea and insufficient direct evidence linking his current condition to his active duty service.

The Board has decided that the issues of entitlement to service connection for PTSD and prostate cancer need further review due to new evidence submitted after a previous decision.

The Board has granted service connection for prostate cancer due to herbicide agent exposure during the Veteran's service in or near the Korean DMZ. The claims for kidney stones, cysts on adrenal glands, and vestibular dysfunction with vertigo, balance issues, and nausea are remanded.

The claims for SMC based on housebound criteria, a rating in excess of 100 percent for prostate cancer, and service connection for focal segmental glomerulosclerosis have been dismissed.,The claim for an initial rating in excess of 10 percent for left leg neuropathy has been denied.,The claim for an initial rating in excess of 10 percent for right leg neuropathy has been denied.

The rating reduction for prostate cancer from 100 percent to 0 percent was not proper, and the 100 percent rating is restored, effective May 1, 2020.

The Veteran's prostate cancer, diagnosed after service and presumed to be related to in-service herbicide exposure, is granted as service connected.

The Board has decided to remand the Veteran's claims for entitlement to service connection for prostate cancer and coronary artery disease due to new evidence submitted after previous decisions. The VA will now review these claims with the new information.

The Board has found new and relevant evidence to warrant readjudication of the claim for service connection for prostate cancer. However, the Veteran's claim is denied as there is no credible evidence of exposure to herbicide agents during his active duty service at Fort Hood, Texas.

The Veteran's service connection claims for coronary artery disease, prostate cancer, diabetes mellitus, and peripheral neuropathy have been granted with effective dates based on the date of the PACT Act.,Effective August 10, 2022, the Veteran has received disability compensation for his heart condition, prostate cancer, and diabetes.

The Board denied the Veteran's claim for service connection for residuals of prostate cancer, finding that there was no objective evidence indicating a qualifying chronic disability and concluding that the condition did not meet the criteria for a MUCMI. The Board also determined that the Veteran's prostate cancer residuals were not incurred in or aggravated by his active military service or his service-connected gastrointestinal disability.

The Veteran's prostate cancer is presumed to have been caused by herbicide exposure during service in Thailand, and the appeal for service connection is granted based on the PACT Act.

The Veteran's appeal of service connection for prostate cancer is remanded due to new evidence being added to the file, and a supplemental statement of the case (SSOC) needs to be issued by the AOJ.

The Veteran's prostate cancer residuals are currently rated at 20 percent, and the Board has remanded to determine if a higher rating is warranted based on updated medical records and an adequate examination.

The Board has decided to remand several issues including service connection for prostate cancer and leukemia claimed as a result of exposure to toxic chemicals, due to the need for additional information from the Kentucky Army National Guard.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence to support a direct or presumptive link between his condition and military service. The Board also found that the Veteran did not have exposure to herbicide agents during service.